Navigation Links
Transcranial magnetic stimulation: An effective treatment for depression
Date:12/5/2007

Philadelphia, PA, December 5, 2007 For the first time in a large-scale study, transcranial magnetic stimulation has been shown to be an effective, non-drug treatment for major depression. Current antidepressant therapies are not beneficial for at least a third of depressed individuals, leaving many with a lack of adequate treatment options. Transcranial magnetic stimulation (TMS), a non-invasive technique that excites neurons in the brain by magnetic pulses introduced through the scalp, has previously been identified as a potential new treatment for depression but prior, smaller studies have shown conflicting results. This new study, published in the December 1st issue of Biological Psychiatry, now shares its findings.

OReardon and colleagues present the results from the first large scale, multi-center, double-blind, sham-controlled study of TMS as a treatment for people with depression who had not responded to prior antidepressants and who were not taking antidepressant medications during the study. After 4-6 weeks of active or sham TMS, response and remission rates with active TMS were approximately twice those of sham. This study was also associated with a low dropout rate, due to generally mild side effects, indicating that the treatment was well-tolerated by patients.

Dr. OReardon, the corresponding author on this project and Associate Professor of Psychiatry at the University of Pennsylvania, explains, "These results indicate that TMS provides a novel and attractive treatment option for patients with major depression who have not responded to conventional antidepressant medications. John H. Krystal, M.D., Editor of Biological Psychiatry and affiliated with both Yale University School of Medicine and the VA Connecticut Healthcare System, highlights the significance of this articles findings: This study provides new support for the efficacy of TMS as a stand alone treatment for depression. This finding could be particularly impor
'/>"/>

Contact: Jayne Dawkins
ja.dawkins@elsevier.com
212-239-3674
Elsevier
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Penn research shows transcranial magnetic stimulation effective in treating major depression
2. Stereotaxis Highlights New Data on Acute Success in AFib Treatments With Niobe Magnetic Navigation System
3. Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System
4. Stereotaxis Highlights Live Coronary and Peripheral Vascular Cases Performed at TCT With Stereotaxis Magnetic Navigation System
5. A Magnetic Presence: Siemens New MRI Systems Pulling More Patients Toward the Benefits of MR Imaging
6. Bayer HealthCare Pharmaceuticals and MedAssets Supply Chain Systems Sign a Three-Year Agreement for Magnevist(R) Magnetic Resonance Contrast Media
7. New treatment effective in counteracting cocaine-induced symptoms
8. Use of certain lipid measures not more effective in predicting coronary heart disease
9. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
10. Effectiveness of mouse breeds that mimic Alzheimers disease symptoms questioned
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... Reporter , , TUESDAY, May 22 (HealthDay News) -- ... procedure, which involves threading a camera through the ... But a new study has found that patients ... less time-consuming CT-based colon scan. Colonoscopy ... colon cancer screening. Computed tomography (CT) colonography -- ...
(Date:5/23/2012)... ATS 2012, SAN FRANCISCO The number of viral ... in childhood, according to a new study from researchers ... infancy predicted wheezing later in childhood, this association was ... , "Viral infections in infancy, particularly rhinovirus, are thought ... but it is unclear whether this association is due ...
(Date:5/23/2012)... tiny, resilient metal wire designed to gather and compress ... severe heterogeneous emphysema, a subtype of the disease that ... to the results of a multicenter international trial conducted ... a lung volume reduction coil (LVRC), can be easily ... more invasive procedures used to improve the lung function ...
(Date:5/23/2012)... ROCHESTER, Minn. -- Mayo Clinic researchers will present ... other urological research at the annual meeting of ... Mayo Clinic urologists will also be available to ... , Mayo Clinic studies that will be presented ... negative impact on overall survival from post-prostate surgery ...
(Date:5/22/2012)... Bend, OR Bend Research Inc., a ... announced the expansion of its existing hot-melt ... an 18mm Leistritz twin-screw mixer/extruder. , ... Research,s existing 27mm Leistritz and 19mm Baker ... and continuous high-shear wet-granulation capabilities. Many projects ...
Breaking Medicine News(10 mins):Health News:Patients Prefer More Invasive Form of Colon Scan: Study 2Health News:Patients Prefer More Invasive Form of Colon Scan: Study 3Health News:Viral infections in infancy are not associated with wheezing symptoms in later childhood 2Health News:Tiny implanted coil improves lung function in patients with severe emphysema 2Health News:Tiny implanted coil improves lung function in patients with severe emphysema 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 4
... for local clinics and health technology projectsPORTLAND, Ore., ... eight grants geared toward building healthier communities and ... and Washington. The grants, totaling $380,000, range from ... quality Web site."The Regence Foundation believes philanthropy is ...
... to have a synergistic effect in the development of ... is a genetic disorder, mostly resulting from mutations in ... metabolism which leads to iron accumulation that may eventually ... between iron metabolism, HFE mutations and alcoholic liver disease ...
... is manifested in a variety of tissues and cancer ... currently being studied as a novel treatment. The PPAR-gamma ... via differentiation, apoptotic induction, and changes in genes or ... have been some reports suggesting that stomach cancer cells ...
... BISMARCK, N.D., Feb. 17 Due to the ... across the United States, Bismarck and,surrounding area optometrists ... assessments for infants between six to 12 months,of ... developed,by the American Optometric Association (AOA) in partnership ...
... pressure affects use of sunscreen, coverups, study finds , , TUESDAY, ... likely to follow sun safety measures if their peers do ... in Atlanta. , Lifeguards and aquatic instructors at outdoor ... M. Hall and colleagues at the university,s Rollins School of ...
... the treatment of epilepsy in children, in many cases ... of vision. Serge Picaud, head of research at Inserm, ... have just discovered the origin of this secondary effect ... shown that vigabatrin provokes a marked decrease in the ...
Other Medicine News:Health News:Grants Strengthen the Health Care Safety Net 2Health News:Grants Strengthen the Health Care Safety Net 3Health News:What is the suppressing effect of the PPAR-gamma ligands on stomach cancer cells? 2Health News:ND Optometrists Partner With U.S. Sens. Conrad and Dorgan, Rep. Pomeroy and Gov. Hoeven in Improving Infant Eye and Vision Care 2Health News:ND Optometrists Partner With U.S. Sens. Conrad and Dorgan, Rep. Pomeroy and Gov. Hoeven in Improving Infant Eye and Vision Care 3Health News:ND Optometrists Partner With U.S. Sens. Conrad and Dorgan, Rep. Pomeroy and Gov. Hoeven in Improving Infant Eye and Vision Care 4Health News:ND Optometrists Partner With U.S. Sens. Conrad and Dorgan, Rep. Pomeroy and Gov. Hoeven in Improving Infant Eye and Vision Care 5Health News:ND Optometrists Partner With U.S. Sens. Conrad and Dorgan, Rep. Pomeroy and Gov. Hoeven in Improving Infant Eye and Vision Care 6Health News:On Sun Safety, Pool Staff May Take Cue From Others 2Health News:Taurine: Key to the visual toxicity of an anti-epileptic drug for children? 2Health News:Taurine: Key to the visual toxicity of an anti-epileptic drug for children? 3
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ), ... commercialization of products for central nervous system disorders, ... at the Society for Research on Biological Rhythms ... The first poster entitled Pleiomorphic Expression of ... insight into the challenges faced by individuals suffering ...
(Date:5/22/2012)... ALLEGAN, Mich., May 22, 2012  Perrigo Company ... final approval from the U.S. Food and Drug ... for butoconazole nitrate 2% vaginal cream, the generic ... submit a substantially complete ANDA with a paragraph ... marketing exclusivity. Perrigo is working exclusively with KV Pharmaceutical ...
(Date:5/22/2012)... Generics, a division of Prodigy Health Supplier Corporation ... generic equivalent of the branded drug Camptosar by ... Laboratories to develop a portfolio of oncology products. ... developed through the partnership that will add consistent ... market, which has experienced record levels of shortages ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 1GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 2GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 4ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 1ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 1MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 3MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 4
... and CHAPEL HILL, N.C., US, March 06, ... Orphan") and,Lantibio, Inc. ("Lantibio") today announced positive ... II clinical,study of Moli1901, an experimental compound ... developed by AOP Orphan in,Europe under a ...
... Accentia,Biopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters at,the ... Asthma, and,Immunology from February 23 - 27, 2007 ... a survey of 202 otolaryngologists,(ENTs) and allergists in ... of chronic sinusitis (CS), the knowledge and attitudes ...
Other Medicine Technology:AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 2AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 3AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 4Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 2Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 3Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 4Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology 5
Designed to provide more effective infusion, .90mm(20 G) ultra thinwall cannula with 45 beveled tip allows 30 percent more fluid flow than a regular wall cannula...
...
...
...
Medicine Products: